Logo
x

Search

Subscribe Now

Hemophilia A

Genentech Reports New Data of Hemlibra (emicizumab-kxwh) in P-IIIb STASEY Study to Treat Hemophilia A

Genentech Reports New Data of Hemlibra (emicizumab-kxwh) in P-IIIb STASEY Study to Treat Hemophilia A

  • July 19, 2021
BioMarin Reports Results of Valoctocogene Roxaparvovec in P-III GENEr8-1 Study for Hemophilia A

BioMarin Reports Results of Valoctocogene Roxaparvovec in P-III GENEr8-1 Study for Hemophilia A

  • January 11, 2021
Pfizer and Sangamo's Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A

Pfizer and Sangamo's Giroctocogene Fitelparvovec (SB-525) Demonstrate Positive Effect in P-I/II Alta Study for Hemophilia A

  • June 19, 2020
BioMarin Receives the US FDA's Priority Review Acceptance of Valoctocogene Roxaparvovec's BLA for Patients with Hemophilia A

BioMarin Receives the US FDA's Priority Review Acceptance of Valoctocogene Roxaparvovec's BLA for Patients with Hemophilia A

  • February 21, 2020
Novo Nordisk Launches Esperoct [antihemophilic factor (recombinant)- glycopegylated-exei] to Treat Hemophilia A in the US

Novo Nordisk Launches Esperoct [antihemophilic factor (recombinant)- glycopegylated-exei] to Treat Hemophilia A in the US

  • February 12, 2020
Bluebird Bio Signs a Three-Year Research Collaboration with Novo Nordisk to Develop In-Vivo Genome Editing Therapies for Hemophilia A

Bluebird Bio Signs a Three-Year Research Collaboration with Novo Nordisk to Develop In-Vivo Genome Editing Therapies for Hemophili...

  • October 9, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.